Multiple sclerosis: relating MxA transcription to anti-interferon-beta-neutralizing antibodies

Neurology. 2007 Mar 20;68(12):958-9. doi: 10.1212/01.wnl.0000257128.53775.62.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / blood*
  • Antibodies / drug effects
  • Biomarkers / blood
  • Female
  • GTP-Binding Proteins / genetics*
  • Humans
  • Interferon-beta / adverse effects*
  • Interferon-beta / immunology*
  • Male
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology*
  • Myxovirus Resistance Proteins
  • Predictive Value of Tests
  • Time Factors
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / immunology
  • Up-Regulation / drug effects
  • Up-Regulation / immunology

Substances

  • Antibodies
  • Biomarkers
  • MX1 protein, human
  • Myxovirus Resistance Proteins
  • Interferon-beta
  • GTP-Binding Proteins